Shanap, M. A., Hashem, H., Khattab, E., Zandaki, D., Rahman, Z. A., Sultan, I., Rihani, R. (2025). Pre-transplant minimal residual disease (MRD) negativity predicts superior GVHD-free/relapse-free survival after allogeneic HCT in pediatric acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2025-7818